The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Vyjuvek for the ...
An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on 20 April 2021.
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
Results of the Planned Interim Analysis and Update on Topline Read-out for the Essential3 Program: The Independent Data ...
Medicines account for more than 13 per cent – about €3.3 billion – of a health budget that is permanently under strain. That ...
Eli Lilly (LLY) and Company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive ...
Neurotech International has received positive feedback from the European Medicines Agency (EMA) on the company’s Orphan ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
Ireland’s medicines approval system is no longer fit for purpose, but is the government committed to renewing it fairly?
One of the main challenges identified by the research was that, although the European Medicines Agency (EMA) approves new ...
C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to ...